- Country: USA
- Summary: 2026 Southern Hemisphere Influenza Vaccine
- UST Ref No: 122055567
- Deadline: 04 Aug 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: SPE2DP25R0004
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The Defense Logistics Agency- Troop Support is seeking sources capable of providing Southern Hemisphere Influenza Vaccine for 2026 season. Shall be trivalent vaccine, licensed by the FDA, intended for active immunization for the prevention of influenzas for the Southern Hemisphere. Shall meet the minimum formula for the influenza vaccine as determined by the FDA-s Vaccines and Related Biological Products Advisory Committee. Shall be pre-measured 0.5ML dose, each dose shall be pre-filled in a commercially available syringe for intramuscular administration in healthy individuals aged 6 months and older. Shall be free of thimerosal or other preservatives. Shall be shipped refrigerated between 2° and 8° C. The vaccine must not be frozen. Shall be one package containing 10 pre-filled syringes as the unit of issue. Product shall be both FDA Approved and ACIP Recommended.
DLA Troop Support has an annual estimated requirement for Southern Hemisphere Influenza Vaccine of 60,000 doses for the 2026 season. However, the quantity may increase or decrease as the Services requirements change. The vaccine shall be delivered to the Defense Distribution Center (DDC) in Susquehanna, PA, and the desirable delivery time is mid-March 2026.
This is a request for information (RFI) and does not commit the U.S. Government to issue a solicitation, make an award, or pay any costs associated with responding to the RFI. All submitted information shall remain with the U.S. Government and will not be returned.
*** Currently Marketed Southern Hemisphere Influenza***
If your firm currently markets Southern Hemisphere Influenza Vaccine, please provide information with respects to the following:
Place of Manufacture Estimated Annual Capacity FDA Registration information Product Name and description including description of any special features Current unit sales price Estimated inventory level and storage requirements Delivery days for this item and earliest produc... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN2026 Southern Hemisphere Influenza Vaccine - USA Tender
The DEPT OF DEFENSE | DEFENSE LOGISTICS AGENCY, a Government sector organization in USA, has announced a new tender for 2026 Southern Hemisphere Influenza Vaccine. This tender is published on USARFP under UST Ref No: 122055567 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-04.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
